These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36556905)

  • 1. Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy.
    Hsu AY; Lin CY; Lin CJ; Lai CT; Hsia NY; Lin JM; Tien PT; Meng PP; Ku WN; Chen WL; Tsai YY
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556905
    [No Abstract]   [Full Text] [Related]  

  • 2. Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration.
    Enríquez AB; Baumal CR; Crane AM; Witkin AJ; Lally DR; Liang MC; Enríquez JR; Eichenbaum DA
    JAMA Ophthalmol; 2021 Apr; 139(4):441-448. PubMed ID: 33630045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration].
    Book M; Ziegler M; Rothaus K; Faatz H; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Ophthalmologe; 2022 Mar; 119(3):258-264. PubMed ID: 34351479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT; Omizo JN; Kokame KA; Yamane ML
    Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 6. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis.
    Schmidt-Erfurth U; Mulyukov Z; Gerendas BS; Reiter GS; Lorand D; Weissgerber G; Bogunović H
    Eye (Lond); 2023 Apr; 37(6):1160-1169. PubMed ID: 35523860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFECT OF RANIBIZUMAB AND AFLIBERCEPT ON RETINAL PIGMENT EPITHELIAL DETACHEMENT, SUBRETINAL AND INTRARETINAL FLUID IN AGE-RELATED MACULAR DEGENERATION.
    Sumarová P; Ovesná P; Matušková V; Beránek J; Michalec M; Michalcová L; Autrata D; Vysloužilová D; Chrapek O
    Cesk Slov Oftalmol; 2022; 78(4):176-185. PubMed ID: 35922146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to brolucizumab treatment for refractory serous pigment epithelial detachment secondary to polypoidal choroidal vasculopathy.
    Nam SW; Byun Z; Ham DI; Kong M
    BMC Ophthalmol; 2022 Dec; 22(1):485. PubMed ID: 36514022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of monitoring wet age-related macular degeneration patients during Coronavirus disease 19 pandemic: A retrospective study of assessment of functional and structural outcomes.
    Tsiropoulos GN; Vallee R; Gallo Castro D; Ambresin A
    J Fr Ophtalmol; 2022 Oct; 45(8):852-859. PubMed ID: 35908993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OUTCOME OF INTRAVITREAL AFLIBERCEPT FOR REFRACTORY PIGMENT EPITHELIAL DETACHMENT WITH OR WITHOUT SUBRETINAL FLUID AND SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kim K; Kim ES; Kim Y; Yang JH; Yu SY; Kwak HW
    Retina; 2019 Feb; 39(2):303-313. PubMed ID: 29160779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-neovascular age-related macular degeneration with subretinal fluid.
    Hilely A; Au A; Freund KB; Loewenstein A; Souied EH; Zur D; Sacconi R; Borrelli E; Peiretti E; Iovino C; Sugiura Y; Ellabban AA; Monés J; Waheed NK; Ozdek S; Yalinbas D; Thiele S; de Moura Mendonça LS; Lee MY; Lee WK; Turcotte P; Capuano V; Filali Ansary M; Chakravarthy U; Lommatzsch A; Gunnemann F; Pauleikhoff D; Ip MS; Querques G; Holz FG; Spaide RF; Sadda S; Sarraf D
    Br J Ophthalmol; 2021 Oct; 105(10):1415-1420. PubMed ID: 32920528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
    Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
    Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QUANTITATIVE ANALYSIS OF PIGMENT EPITHELIAL DETACHMENT RESPONSE TO DIFFERENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN WET AGE-RELATED MACULAR DEGENERATION.
    Balaskas K; Karampelas M; Horani M; Hotu O; Keane P; Aslam T
    Retina; 2017 Jul; 37(7):1297-1304. PubMed ID: 27755376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
    Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
    BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study.
    Chakraborty D; Maiti A; Sengupta S; Mondal S; Nandi K; Chakraborty S
    Indian J Ophthalmol; 2022 Apr; 70(4):1295-1299. PubMed ID: 35326038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
    Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM
    Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
    Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.
    Tamashiro T; Tanaka K; Itagaki K; Nakayama M; Maruko I; Wakugawa S; Terao N; Onoe H; Wakatsuki Y; Ogasawara M; Sugano Y; Yamamoto A; Kataoka K; Izumi T; Kawai M; Mori R; Sekiryu T; Okada AA; Iida T; Koizumi H;
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1857-1865. PubMed ID: 35034215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.